AKT1 and colorectal cancer: In previous studies, LAMB3 was also reported to promote tumor progression and chemoresistance through the AKT-FOXO3/4 axis and be transcriptionally regulated by the BRD2/acetylated ELK4 complex [41] and polymeric immunoglobulin receptor [42] in colorectal cancer.